MetaCap

Aspen Neuroscience (ASPE) vs MapLight Therapeutics (MPLT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Aspen Neuroscience is the larger company by market cap ($361.2 million vs $330.1 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASPE-16.59%MPLT-21.64%
+1%-11%-23%
Oct 30, 20261 yearNov 20, 2026
ASPE-16.59%MPLT-21.64%
+1%-11%-23%
Oct 26, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASPE versus MPLT key metrics
MetricASPEMPLT
Share price$12.42$5.94
Market cap$361.16M$330.12M
1-day change+0.24%-7.48%
YTD return—-66.18%
1-year return—-57.54%
EPS (TTM)$-4.89$-6.07
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)—$-161.15M
52-week high$14.90$40.43
52-week low$11.20$5.93
Distance from 52-week high-16.64%-85.31%
Analyst consensus—strong_buy
Avg. price target upside—+340.24%
Average volume352.42K458.71K
Shares outstanding29.08M52.85M
Employees120133
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Aspen Neuroscience

ASPE stock →

Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 120 employees

About MapLight Therapeutics

MPLT stock →

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.

Health Care · Biotechnology: Pharmaceutical Preparations · 133 employees

ASPE vs MPLT FAQ

Which is bigger, Aspen Neuroscience or MapLight Therapeutics?

Aspen Neuroscience (ASPE) is larger, with a market capitalization of $361.16M compared with $330.12M for MapLight Therapeutics (MPLT).

Are Aspen Neuroscience and MapLight Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons